Results 141 to 150 of about 34,079 (221)

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. [PDF]

open access: yes, 2019
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis largely owing to inefficient diagnosis and tenacious drug resistance. Activation of pancreatic stellate cells (PSCs) and consequent development of dense stroma are prominent features ...
Antal, Corina E   +37 more
core  

Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma [PDF]

open access: yes, 2018
Metabolomics as one of the most rapidly growing technologies in the "-omics” field denotes the comprehensive analysis of low molecular-weight compounds and their pathways.
Ceglarek, Uta   +9 more
core  

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer. [PDF]

open access: yes, 2019
BackgroundTreatment outcomes for patients with advanced pancreatic ductal adenocarcinoma (PDAC) remain dismal. There are unmet needs for understanding the biologic basis of this malignancy using novel next-generation sequencing technologies.
Fanta, Paul   +7 more
core   +1 more source

Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0–I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer

open access: yesCancer Management and Research, 2018
Jianyuan Song,* Xiaoxue Huang,* Zhuhong Chen, Mingqiu Chen, Qingliang Lin, Anchuan Li, Yuangui Chen, Benhua Xu Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, People’s Republic of China *These ...
Song JY   +7 more
doaj  

Hepatocellular jaundice with abnormally high CA19-9: A case report. [PDF]

open access: yesMedicine (Baltimore)
Cui Y, Zhang Y, Huang Y, Feng R, Chen Q.
europepmc   +1 more source

A rare case of pulmonary sequestration with elevated CA19-9 levels. [PDF]

open access: yesAnn Med Surg (Lond)
Zhang MM, Jin X, Li J, Wu X, Wang C.
europepmc   +1 more source

CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. [PDF]

open access: yesCancers (Basel)
Brancato L   +6 more
europepmc   +1 more source

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study. [PDF]

open access: yesAdv Sci (Weinh)
Chen Q   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy